Trial intelligence / Profile preview

WRAIR Live Attenuated Tetravalent Dengue Vaccine in Healthy Adults and Children

NCT00468858Phase 2Completed

Sponsor
U.S. Army Medical Research and Development Command
Start
Jul 2007
Primary completion
Apr 2010
Countries
1
01

Overview

A Phase 2 trial of T-DEN vaccine in dengue fever, dengue hemorrhagic fever (DHF), dengue shock syndrome (DSS), sponsored by U.S. Army Medical Research and Development Command. Started Jul 2007; status: completed.

02

Drugs

T-DEN vaccine
03

Conditions

dengue feverdengue hemorrhagic fever (DHF)dengue shock syndrome (DSS)

Beyond the preview

Go deeper on NCT00468858.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00468858.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call